This site uses cookies.
Learn more.

×

This website uses cookies. Some of the cookies we use are essential for parts of the website to operate while others offer you a better browsing experience. You give us your permission to use cookies, by continuing to use our website after you have received the cookie notification. To find out more about cookies on this website and how to change your cookie settings, see our Privacy policy and Terms of Use.

Translating Genetics into Medicine

Translating Genetics into Medicine

Thursday, April 25, 2019, 8:30 AM - 6:00 PM

The New York Academy of Sciences, 7 World Trade Center, 250 Greenwich St Fl 40, New York

Presented By

The Biochemical Pharmacology Discussion Group

The New York Academy of Sciences

 

The first genome-wide association studies (GWASs) began unraveling the genetic basis of complex diseases over a decade ago. In that time, the development of innovative analytical and experimental methods enabled genomic data to inform how genetics relates to human traits, health, and disease. Nevertheless, progress has stalled in translating genetic association signals to an understanding of their underlying biological mechanisms, in identifying causal links between genetic variants and phenotypes, and in developing therapies based on this knowledge — few drug targets identified through GWASs have advanced.

This symposium will highlight emerging strategies to experimentally and computationally identify and validate causal association from patient cohorts, and outline the challenges and opportunities in translating GWAS hits into successful drug discovery programs.

Call for Abstracts

Abstract submissions are invited for a poster session. For complete submission instructions, please visit our online portal. The deadline for abstract submission is Thursday, February 28, 2019.

Registration

Member
By 03/14/2019
$90
After 03/14/2019
$130
Nonmember Academia, Faculty, etc.
By 03/14/2019
$180
After 03/14/2019
$260
Nonmember Corporate, Other
By 03/14/2019
$250
After 03/14/2019
$350
Nonmember Not for Profit
By 03/14/2019
$180
After 03/14/2019
$260
Nonmember Student, Undergrad, Grad, Fellow
By 03/14/2019
$100
After 03/14/2019
$145
Member Student, Post-Doc, Fellow
By 03/14/2019
$50
After 03/14/2019
$70
Earlybird Registration:
56
days
left
Deadline:
41
days
left

Keynote Speakers

Richard P. Lifton, MD, PhD,
The Rockefeller University
Robert Plenge, MD, PhD,
Celgene

Speakers

Christopher Brown, PhD,
University of Pennsylvania
Molly Gasperini,
University of Washington
Rajat Gupta, MD,
Broad Institute, Massachusetts General Hospital, and Harvard Medical School
Ruth Loos, PhD,
Icahn School of Medicine at Mount Sinai
Matthew Nelson, PhD, MA,
GlaxoSmithKline
Daniel J. Rader, MD,
Perelman School of Medicine, University of Pennsylvania
Timothy E. Reddy, PhD,
Duke University

Scientific Organizing Committee

Judy Cho, MD,
Icahn School of Medicine at Mount Sinai
Caroline Fox, MD,
Merck Research Labs
Paolo Guarnieri, MD,
Boehringer Ingelheim
Julie Hawkins, PhD,
Boehringer Ingelheim
Tuuli Lappalainen, PhD,
Columbia University; The New York Genome Center
Alan Shuldiner, MD,
Regeneron Pharmaceuticals and University of Maryland
Dawn Waterworth, PhD,
Glaxo Smith Kline
Alison Carley, PhD,
The New York Academy of Sciences
Sonya Dougal, PhD,
The New York Academy of Sciences



Thursday

April 25, 2019

8:30 AM

Continental Breakfast and Registration

9:00 AM

Introduction and Welcome Remarks

Speaker

Alison Carley, PhD
The New York Academy of Sciences

Session 1: Linking Disease to Genetic Variation

Session Chairperson
Dawn Waterworth, PhD, Glaxo Smith Kline
9:15 AM

Title to be announced

Speaker

Ruth Loos, PhD
Icahn School of Medicine at Mount Sinai
9:45 AM

Title to be announced

Speaker

Christopher Brown, PhD
University of Pennsylvania
10:15 AM

Title to be announced

Speaker

Timothy E. Reddy, PhD
Duke University
10:45 AM

Networking Coffee Break

Session 2: Data Blitz Presentations

Session Chairperson
Paolo Guarnieri, MD, Boehringer Ingelheim
11:15 AM

Selection from poster abstract submissions

11:20 AM

Selection from poster abstract submissions

11:25 AM

Selection from poster abstract submissions

Session 3: Keynote Address

Session Chairperson
Judy Cho, MD, Icahn School of Medicine at Mount Sinai
11:30 AM

Keynote Address

Speaker

Richard P. Lifton, MD, PhD
The Rockefeller University
12:15 PM

Networking Lunch

Session 4: Characterizing Functional Relevance of Genetic Variants

Session Chairperson
Julie Hawkins, PhD, Boehringer Ingelheim
1:15 PM

Title to be announced

Speaker

Rajat Gupta, MD
Broad Institute, Massachusetts General Hospital, and Harvard Medical School
1:45 PM

Title to be announced

Speaker

Molly Gasperini
University of Washington
2:15 PM

Title to be announced

Speaker

Daniel J. Rader, MD
Perelman School of Medicine, University of Pennsylvania
2:45 PM

Networking Coffee Break

Session 5: Emerging Opportunities in Genetics for New Therapeutics

Session Chairperson
Alan Shuldiner, MD, Regeneron Pharmaceuticals and University of Maryland
3:15 PM

Title to be announced

Speaker

Matthew Nelson, PhD, MA
GlaxoSmithKline
3:45 PM

Keynote Address

Speaker

Robert Plenge, MD, PhD
Celgene
4:30 PM

Panel Discussion: The Future of Transformational Genetics

Speakers

Moderator: Alan Shuldiner, MD
Regeneron Pharmaceuticals and University of Maryland
Panelists to be announced
5:00 PM

Poster Session & Networking Reception

6:00 PM

F1000 Poster Prize Presentation and Closing Remarks

6:15 PM

Adjourn